Showing results (311-320 of 6,499) with videos related to
Sort By:
Pageof 650
Cancer Immunology, Immunotherapy : CII|July 24, 2013
Vaccination of castration-resistant prostate cancer patients with TroVax (MVA-5T4) in combination with docetaxel: a randomized phase II trialRichard Harrop, Franklin Chu, Nashat Gabrail, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1990
Characterization of effector cells of graft vs leukemia following allogeneic bone marrow transplantation in mice inoculated with murine B-cell leukemiaL Weiss, M Weigensberg, S Morecki, et al.Cancer Immunology, Immunotherapy : CII|April 11, 2012
Co-delivery of antigen and IL-12 by Venezuelan equine encephalitis virus replicon particles enhances antigen-specific immune responses and antitumor effectsTakuya Osada, Peter Berglund, Michael A Morse, et al.Cancer Immunology, Immunotherapy : CII|May 31, 2012
Combined immunotherapy with Listeria monocytogenes-based PSA vaccine and radiation therapy leads to a therapeutic response in a murine model of prostate cancerRaquibul Hannan, Huagang Zhang, Anu Wallecha, et al.Cancer Immunology, Immunotherapy : CII|May 4, 2012
Toll-like receptor 4 gene polymorphism influences dendritic cell in vitro function and clinical outcomes in vaccinated melanoma patientsAndrés Tittarelli, Fermín E González, Cristián Pereda, et al.Cancer Immunology, Immunotherapy : CII|October 9, 2013
Clinical evaluation of systemic and local immune responses in cancer: time for integrationDmitriy W Gutkin, Michael R ShurinCancer Immunology, Immunotherapy : CII|October 2, 2013
Recipient leukocyte infusion enhances the local and systemic graft-versus-neuroblastoma effect of allogeneic bone marrow transplantation in miceLeen Willems, Sabien Fevery, Ben Sprangers, et al.Cancer Immunology, Immunotherapy : CII|April 1, 1997
Markedly induced asialoGM1+CD8+ T cell production and enhancement of antimetastatic activity by interferon beta with folic or folinic acidM Iigo, M Moriyama, I Suzuki, et al.Cancer Immunology, Immunotherapy : CII|April 1, 1997
Prevention of superantigen-induced tolerance in vivo by interleukin-2 treatmentH Belfrage, M Dohlsten, G Hedlund, et al.Cancer Immunology, Immunotherapy : CII|April 1, 1997
Cellular characteristics of peripheral blood lymphocytes and tumour-infiltrating lymphocytes in patients with gynaecological tumoursT Schöndorf, H Engel, C Lindemann, et al.Pageof 650